About 1 500 reports

China’s demand for Prostate Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export,...

  • Prostate Cancer
  • Hormone
  • China
  • Industrial Production
  • Labour Force

Melanocyte Stimulating Hormone Receptor - Drugs In Development, 2021 Summary Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) - Melanocyte-stimulating hormone receptor (MSHR) also known as melanocortin 1 receptor (MC1R), is a G protein-coupled receptor that binds...

  • Pharmaceutical
  • Hormone
  • World
  • Drug Approval
  • Hospital Admission

Reproductive Hormones and Proteins Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Reproductive Hormones and Proteins Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Reproductive Hormones and Proteins Tests...

  • Hormone
  • Clinical Trial
  • World
  • Direct Sales
  • Milk Production

Major players in the parathyroid hormone market are Pfizer Inc., Eli Lilly and Company, Radius Health Inc., Shire, Ascendis Pharma, Entera Bio Ltd., Extend Biosciences Inc. and Gedeon Richter Plc. The global parathyroid hormone market is expected to grow from $2.02 billion in 2021 to $2.15 billion in 2022 at a compound annual growth...

  • Hormone
  • World
  • United States
  • Japan
  • Middle East
  • APAC

Major players in the drugs for hormonal replacement therapy market are Novartis AG, Bayer AG, Pfizer Inc., Novo Nordisk A/S, Eli Lilly and Company, Abbott, Mylan Laboratories, Merck & Co, Hisamitsu Pharmaceutical Co Inc, Teva Pharmaceutical Industries Ltd., F. Hoffmann-La Roche, Noven Pharmaceuticals Inc., Orion Pharma AB, Allergan Plc, QuatRx...

  • Hormone
  • World
  • South Korea
  • Middle East
  • India
  • APAC

Major players in the biosimilar hormones market are Teva Pharmaceutical, Gedeon Richter, Intas Pharmaceuticals, Biocon, Mylan, Sanofi, Sandoz (Novartis), LG Life Sciences, Ferring Pharmaceuticals and GC Pharma. The global biosimilar hormones market is expected to grow from $1.74 billion in 2021 to $2.31 billion in 2022 at a compound...

  • Hormone
  • World
  • Europe
  • Australia
  • APAC
  • Biosimilar Sales
  • Biologics Approval

Major players in the biosimilar hormones market are Teva Pharmaceutical, Gedeon Richter, Intas Pharmaceuticals, Biocon, Mylan, Sanofi, Sandoz (Novartis), LG Life Sciences, Ferring Pharmaceuticals, and GC Pharma. The global biosimilar hormones market is expected to grow from $1.94 billion in 2020 to $2.19 billion in 2021 at a compound...

  • Hormone
  • World
  • Europe
  • Australia
  • United States
  • APAC
  • Biosimilar Sales
  • Biologics Approval

Hormone Replacement Therapy market is one of the high-growth prospect industries with potential opportunities throughout 2028. The Hormone Replacement Therapy Market growth analysis and insights report analyzes emerging market trends, market size outlook, potential opportunities, market share by Hormone Replacement Therapy types, applications....

  • Hormone
  • World

Major players in the drugs for hormonal replacement therapy market are Novartis AG, Bayer AG, Pfizer Inc., Novo Nordisk A/S, and Eli Lilly and Company. The global drugs for hormonal replacement therapy market is expected to grow from $14.76 billion in 2020 to $14.88 billion in 2021 at a compound annual growth rate (CAGR) of 0.8%. The...

  • Hormone
  • World
  • India
  • South Korea
  • APAC

Melanocyte Stimulating Hormone Receptor - Pipeline Review, H2 2020 Summary Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) - Melanocyte-stimulating hormone receptor (MSHR) also known as melanocortin 1 receptor (MC1R), is a G protein-coupled receptor that binds...

  • Pharmaceutical
  • Hormone
  • World
  • Drug Approval
  • Mortality Rate

Hormone replacement therapy (HRT) is used for replenishing the hormones that are present in low levels in the human body. This treatment is particularly favourable for patients with growth hormone deficiency, women nearing menopause and elderly people suffering from hypogonadism. HRT is available in several forms such...

  • Hormone
  • World

Abstract: - Global Hormone Replacement Therapy (HRT) Market to Reach $10.6 Billion by 2027 - Amid the COVID-19 crisis, the global market for Hormone Replacement Therapy (HRT) estimated at US$7.6 Billion in the year 2020, is projected to reach a revised size of US$10.6 Billion by 2027, growing at a CAGR of 4.8% over...

  • Hormone
  • World
  • China
  • United States

Hormone Replacement Therapy Market Report Overview Hormone Replacement Therapy market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Hormone Replacement Therapy market types and applications. It is a focused study on Hormone Replacement Therapy...

  • Hormone
  • World
  • Health Provider Density

Abstract: - Global Endometriosis Drugs Market to Reach $2.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Endometriosis Drugs estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$2.2 Billion by 2027, growing at aCAGR of 2.8% over the period 2020-2027. Hormone...

  • Genitourinary System Disease
  • Pharmaceutical
  • Hormone
  • Analgesic
  • World
  • China
  • United States

Major players in the biosimilar hormones market are Teva Pharmaceutical, Gedeon Richter, Intas Pharmaceuticals, Biocon, Mylan, Sanofi, Sandoz (Novartis), LG Life Sciences, Ferring Pharmaceuticals and GC Pharma. The global biosimilar hormones market is expected to decline from $2.05 billion in 2019 to $1.94 billion in 2020 at a compound...

  • Hormone
  • World
  • Biosimilar Sales
  • Biologics Approval

KEY FINDINGS The global hormone replacement therapy market is estimated to project a CAGR of 7.67% during the forecast period, 2021-2028. The awareness of post-menopausal issues, product launches by major players, and growing hormonal disorders drive market growth. MARKET INSIGHTS HRT (hormone...

  • Hormone
  • APAC
  • World
  • Drug Approval

Abstract: - Global Male Hypogonadism Market to Reach $3.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Male Hypogonadism estimated at US$2.8 Billion in the year 2020, is projected to reach a revised size of US$3.5 Billion by 2027, growing at aCAGR of 2.9% over the period 2020-2027. Testosterone...

  • Cancer Hormonal Therapy
  • Hormone
  • World
  • China
  • United States

Drugs For Hormonal Replacement Therapy Global Market Report 2020-30: Covid 19 Impact and Recovery provides strategists, marketers and senior management with the critical information they need to assess the global drugs for hormonal replacement therapy market as it emerges from the Covid 19 shut down. Description: Where...

  • Human Growth Hormone
  • Marketing Research
  • In-Store Retail
  • Pharmacy
  • Infectious Disease
  • Endocrine Disease
  • Hormone
  • World

Melanocyte Stimulating Hormone Receptor - Pipeline Review, H1 2020 Summary According to the recently published report ’Melanocyte Stimulating Hormone Receptor - Pipeline Review, H1 2020’; Melanocyte Stimulating Hormone Receptor (Melanocortin Receptor 1 or MSHR or MC1R) pipeline Target constitutes...

  • Hormone
  • Pharmaceutical
  • World
  • United States
  • Drug Approval
  • Labour Force

The US compounding pharmacies market is expected to reach US$ 5,069.56 million by 2027 from US$ 3,079.64 million in 2019. The market is anticipated to grow at a CAGR of 6.5% from 2020 to 2027. The growth of the US compounding pharmacy market is attributed to the drug shortage crisis in the US and benefits associated with compounded...

  • Pharmacy
  • Hormone
  • Analgesic
  • United States
  • Use Of Prescription Drugs
  • Drug Approval

Pyruvate Kinase PKM (Cytosolic Thyroid Hormone Binding Protein or Pyruvate Kinase Muscle Isozyme or Opa Interacting Protein 3 or Pyruvate Kinase 2/3 or Tumor M2 PK or PKM2 or Thyroid Hormone Binding Protein 1 or p58 or PKM or EC 2.7.1.40) - Drugs in Development, 2021 Summary Pyruvate Kinase PKM (Cytosolic...

  • Hormone
  • World

Follicle Stimulating Hormone Receptor (Follitropin Receptor or FSHR) - Drugs in Development, 2021 Summary Follicle Stimulating Hormone Receptor (Follitropin Receptor or FSHR) - Drugs in Development, 2021 provides in depth analysis on Follicle Stimulating Hormone Receptor (Follitropin Receptor or...

  • Hormone
  • Research And Development
  • Drug Development
  • World

Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021 Summary Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Hormone Refractory (Castration...

  • Prostate Cancer
  • Hormone
  • World

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021 Summary Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the...

  • Prostate Cancer
  • Hormone
  • World

Protein Disulfide Isomerase (Prolyl 4 Hydroxylase Subunit Beta or Cellular Thyroid Hormone Binding Protein or p55 or P4HB or EC 5.3.4.1) - Drugs in Development, 2021 Summary Protein Disulfide Isomerase (Prolyl 4 Hydroxylase Subunit Beta or Cellular Thyroid Hormone Binding Protein or p55 or P4HB or...

  • Hormone
  • World

Thyroid Hormone Receptor Beta (Nuclear Receptor Subfamily 1 Group A Member 2 or c erbA 2 or c erbA Beta or ERBA2 or THRB) - Drugs in Development, 2021 Summary Thyroid Hormone Receptor Beta (Nuclear Receptor Subfamily 1 Group A Member 2 or c erbA 2 or c erbA Beta or ERBA2 or THRB) - Drugs in Development,...

  • Hormone
  • World

Hormone Replacement Therapy Market Size, Share & Trends Analysis Report By Product (Estrogen, Human Growth), By Route Of Administration (Oral, Parenteral), By Type Of Disease, By Region, And Segment Forecasts, 2020 - 2027 The global hormone replacement therapy market size is expected to reach USD 39.6 billion by 2027,...

  • Hormone
  • World

Thyroid Hormone Receptor Alpha (Nuclear Receptor Subfamily 1 Group A Member 1 or V erbA Related Protein 7 or c erbA 1 or c erbA Alpha or EAR7 or THRA) - Drugs in Development, 2021 Summary Thyroid Hormone Receptor Alpha (Nuclear Receptor Subfamily 1 Group A Member 1 or V erbA Related Protein 7 or...

  • Hormone
  • World

Major players in the market are Mylan N.V., Abbott Laboratories, GlaxoSmithKline plc., Merck & Co., AbbVie Inc., Pfizer Inc., Allergan plc., RLC LABS, Amgen Inc. and Lannett Company Inc. The global anti-thyroid drugs market is expected to grow from $2.32 billion in 2021 to $2.42 billion in 2022 at a compound annual growth rate (CAGR)...

  • Hormone
  • Endocrine Disease
  • World
  • Middle East
  • United States
  • APAC
  • Child Mortality

Hypothyroidism - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Hypothyroidism - Pipeline Review, H2 2020, provides an overview of the Hypothyroidism (Hormonal Disorders) pipeline landscape. Hypothyroidism (underactive thyroid) is a condition...

  • Pharmaceutical
  • Hormone
  • Therapy
  • Endocrine Disease
  • Drug Development
  • World